DeepCyte is a techbio company developing AI-driven toxicology tools for drug development. The company offers solutions to detect, predict, and explain drug toxicity in human cells at single-cell resolution, enabling biopharma teams to improve preclinical safety assessment and understand heterogeneous cellular effects.
Leadership & Board
Current Number of Employees9
Current LinkedIn Followers1,197
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$2M
Total Amount Raised$2M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$2M
Latest Funding Amount$2M
Latest Funding RoundSeed Round
Latest Funding RoundSeed Round
Post-Money Valuation―
Post-Money Valuation―
Employee Trend
DeepCyte had 9 employees as of September 7, 2026. The number of employees decreased by 1 (10.00%) week-over-week.
9Latest Employee Count
1(-10.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
DeepCyte had 1,197 followers as of September 7, 2026. The number of followers increased by 11 (0.93%) week-over-week.
1,197Latest Followers Count
11(0.93%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.
Funding Round
Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Apr 09, 2026
Seed Round
$1.50M
―
Similar Companies
A snapshot of private companies similar to DeepCyte, helping you discover and navigate related company profiles.